Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.
Maclachlan TK, Lukason M, Collins M, Munger R, Isenberger E, Rogers C, Malatos S, Dufresne E, Morris J, Calcedo R, Veres G, Scaria A, Andrews L, Wadsworth S.
Maclachlan TK, et al. Among authors: malatos s.
Mol Ther. 2011 Feb;19(2):326-34. doi: 10.1038/mt.2010.258. Epub 2010 Nov 30.
Mol Ther. 2011.
PMID: 21119620
Free PMC article.